Corpus Intelligence IC Memo — ADVENTIST HEALTH HANFORD 2026-04-26 09:08 UTC
IC Memo — ADVENTIST HEALTH HANFORD
Investment Committee Memorandum | CA | 235 beds | Grade C | EBITDA uplift $25.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ADVENTIST HEALTH HANFORD

CCN 050121 | KINGS, CA | 235 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ADVENTIST HEALTH HANFORD is a 235-bed suburban community hospital in KINGS, CA with $341.1M in net patient revenue and a -5.0% operating margin. The hospital serves a payer mix of 25.9% Medicare, 6.9% Medicaid, and 67.2% commercial.

Thesis: Undervalued. Our ML models identify $25.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.0% to 2.4% (+736bps).

Net Revenue HCRIS$341.1M
Current EBITDA COMPUTED$-16.9M
Operating Margin COMPUTED-5.0%
Occupancy HCRIS54.8%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS23.3%
Distress Probability ML47.0%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
196
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -5.0% places it below the state median. Among 196 size-comparable peers (118-470 beds), the median margin is -3.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (118-470), prioritizing same-state peers. 196 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ADVENTIST HEALTH HANFORD (Target)CA235$341.1M-5.0%
RONALD REAGAN UCLACA446$2.62B-6.8%
LUCILE PACKARD CHILDRENS HOSPICA394$2.39B-0.8%
UCI MEDICAL CENTERCA397$1.90B-2.5%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
RADY CHILDRENS HOSPITAL - SAN CA401$1.82B14.8%
HARBOR-UCLA MEDICAL CENTERCA369$1.54B-6.4%
EL CAMINO HOSPITALCA388$1.34B11.7%
CHILDRENS HOSPITAL OF ORANGE CCA334$1.31B0.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $25.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.2M+210bp18mo
Cost to Collect4.5%2.5%$6.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$6.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.2M+122bp9mo
Clean Claim Rate88.0%96.0%$218K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.2M
Cost to Collect
$6.8M
Denial Rate Reduction
$6.8M
A/R Days Reduction
$4.2M
Clean Claim Rate
$218K
Total EBITDA Uplift$25.1M
Current EBITDA$-16.9M
+ RCM Uplift+$25.1M
Pro Forma EBITDA$8.2M
Current Margin-5.0%
Pro Forma Margin2.4%
WC Released (1x)$13.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-26.1M$139.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-26.1M$144.8M0.00x-100.0%
Bull Case9.0x11.0x$-23.5M$219.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-23.5M$232.1M0.00x-100.0%
Bear Case11.0x10.0x$-28.7M$22.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-28.7M$15.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 196 hospitals with 118-470 beds
  • Same-state prioritization (n=197)
  • Comp margins: P25=-16.3% / P50=-3.9% / P75=4.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.